✓ Platba kartou obnovena — bezpečné platby přes Privacy Shield

Nizonide

✅ Treats parasitic infections
✅ Fights viral gastroenteritis
✅ Reduces diarrhea symptoms
✅ Fast-acting relief
✅ Broad antiparasitic action

Nizonide contains Nitazoxanide.

Lékařsky ověřeno Morgan Ellis — Pharmacy Researcher · 8 years experience Last reviewed: May 2026

Buy more, save more Price per tablet
Select a strength above to see pack pricing.
Šifrovaný nákup
Platba kryptoměnou - sleva 10%
Diskrétní doručení po celém světě
1 400+ zákazníků · 50+ zemí

⚡ Quick Answer — What is Nizonide?

Nizonide is Cipla’s brand of nitazoxanide (200 / 500 mg) — a broad-spectrum antiprotozoal and antiviral. First-line for confirmed Giardia lamblia a Cryptosporidium parvum infections (the only FDA-approved indication), and useful for amoebiasis and selected viral diarrhoeas. Standard adult course is 500 mg twice daily for 3 days, taken with food.

Proč objednávat z MedsBase? Dodáváno od výrobce certifikovaného WHO-GMP · Diskrétní balení · Doprava po celém světě · 1 400+ ověřených recenzí zákazníků

📦 Každá objednávka je pokryta naší Zárukou opětovného odeslání — pokud vaše zásilka nedorazí do 20 pracovních dnů, přeposíláme ji.

Proč objednávat z MedsBase

Naše generické léky pocházejí od výrobců certifikovaných WHO-GMP a jsou expedovány po celém světě v diskrétním, nenápadném balení – na vnější straně balíku není uveden název léku. Platby kartou jsou směrovány prostřednictvím regulovaného procesoru (popisky na výpisu zahrnují regulovaného procesora plateb kartou – nikdy “MedsBase” nebo název léku). Přijímáme také kryptoměny a bankovní převody SEPA. Každá objednávka je zajištěna naší politikou přeposlání.

What Nizonide is for

Nizonide is a thiazolide antiprotozoal manufactured by Cipla. The active ingredient nitazoxanide has a uniquely broad spectrum against intracellular and luminal protozoa, certain helminths, anaerobic bacteria, and a number of RNA viruses. In traveller’s-diarrhoea and tropical-medicine practice it is most commonly used for:

  • Giardiasis — first-line in many countries; alternative to metronidazole and tinidazole. Better tolerated (no disulfiram-like reaction with alcohol) and shorter 3-day course.
  • Cryptosporidiosis — the pouze FDA-approved drug for this infection in immunocompetent adults and children. In severe cryptosporidiosis associated with HIV/AIDS the response is partial — restoration of CD4 count via ART is the central intervention.
  • Amoebiasis (intestinal, off-label) — good activity against Entamoeba histolytica; metronidazole or tinidazole remain preferred for invasive disease.
  • Other protozoaBlastocystis hominis, Cyclospora, Isospora in selected contexts.
  • Helminths (off-label) — Hymenolepis nana (dwarf tapeworm), Ascaris lumbricoides, Trichuris trichiura; albendazole/mebendazole remain preferred first-line.
  • Viral gastroenteritis — clinical-trial evidence supports modest reduction in symptom duration in rotavirus and norovirus diarrhoea (Rossignol JAMA 2009; Rossignol Lancet 2006). Not standard of care; consider in severe or prolonged viral illness.
  • Recurrent Clostridioides difficile infection (off-label salvage) — small case series only; vancomycin and fidaxomicin remain first-line.

How Nizonide works

Nitazoxanide is a prodrug rapidly hydrolysed to its active metabolite tizoxanide in the gut and liver. The mechanism is unique among anti-infectives: it inhibits the pyruvate:ferredoxin oxidoreductase (PFOR) enzyme required for anaerobic energy metabolism in protozoa, anaerobic bacteria, and certain helminths. Because mammalian cells use aerobic mitochondrial metabolism instead, the drug is selectively toxic to the pathogen. Antiviral activity against rotavirus, norovirus, influenza, and hepatitis B/C is mediated through different pathways including interference with viral protein maturation.

Dávkování

IndikaceAdult dosePaediatric (1–11 y)Délka
Giardiasis500 mg BID1–3 y: 100 mg BID · 4–11 y: 200 mg BID3 days
Cryptosporidiosis (immunocompetent)500 mg BID100 / 200 mg BID by age band3 days
Cryptosporidiosis (HIV/CD4 < 200)500–1000 mg BIDSpecialist guidance14 days minimum
Amoebiasis (off-label)500 mg BIDBy age band3 days
Viral gastroenteritis (off-label)500 mg BIDBy age band3 days
✅ Take with food
Nitazoxanide is poorly water-soluble. Taking each dose with food increases AUC roughly 2–3 fold versus fasting. Adherence to this rule is the single biggest predictor of treatment success — failed courses are most often under-absorbed, not under-dosed.

Vedlejší účinky

  • Bright greenish-yellow urine — a harmless and characteristic effect of the tizoxanide metabolite. Resolves within 24–48 hours of stopping the course.
  • Common (1–10%) — abdominal pain, diarrhoea (paradoxically), headache, nausea.
  • Méně časté — vomiting, dyspepsia, skin rash.
  • Vzácné — elevated liver enzymes (usually self-limiting), hypersensitivity reactions.

Interakce léků

Nitazoxanide and tizoxanide are extensively protein-bound (> 99 %). Caution is warranted with other highly protein-bound drugs in narrow therapeutic windows:

  • Warfarin — competition for albumin binding can transiently raise free-warfarin levels; monitor INR closely if co-administered.
  • Fenytoin — similar mechanism; consider level monitoring during co-treatment.
  • Antacids and bile-acid sequestrants — no clinically significant interaction reported, but separate dosing by 2 hours as a precaution.
  • CYP enzymes — nitazoxanide is not a significant CYP substrate or inhibitor at therapeutic doses; CYP-mediated interactions are uncommon.

Contraindications and cautions

  • Těhotenství — limited human data. FDA Pregnancy Category B (animal data reassuring; no controlled human studies). Avoid in first trimester unless benefit clearly outweighs uncertain risk.
  • Kojení — limited data on excretion in breast milk. Short courses generally compatible; avoid prolonged dosing where possible.
  • Children < 1 year — safety not established; specialist supervision only.
  • Těžké jaterní poškození — limited data; specialist supervision.
  • Těžké poškození ledvin (CrCl < 30) — limited data; specialist supervision.
💡 Diagnostic confirmation
Symptomatic protozoal infection should ideally be confirmed by stool microscopy, antigen testing, or PCR before treatment, especially for cryptosporidiosis (which has overlapping symptoms with giardia, viral, and bacterial causes). Empirical nitazoxanide for unspecified “chronic diarrhoea” without diagnostic workup is not recommended — chronic diarrhoea after travel can also reflect post-infectious IBS, microscopic colitis, tropical sprue, or coeliac disease, all of which need different management.

Skladování

Store below 25 °C in the original blister, away from moisture and direct sunlight. Keep out of reach of children. Do not use after expiry — antiprotozoal potency degrades.

Často kladené dotazy

Is Nizonide first-line for traveller’s diarrhoea?

No. Most acute traveller’s diarrhoea is bacterial (ETEC, Campylobacter, Shigella, Salmonella) — for which a single-dose azithromycin or a 1–3 day fluoroquinolone course is first-line. Nizonide becomes appropriate when stool testing identifies a protozoal cause, or in chronic / recurrent / antibiotic-failed diarrhoea suggestive of cryptosporidium or giardia.

Why does my urine turn bright yellow-green on Nizonide?

Tizoxanide, the active metabolite, has an intense yellow chromophore that is excreted renally. The colour is harmless and a normal expected effect — it does not indicate liver or kidney problems. It clears within 24–48 hours of finishing the course.

Can I take Nizonide if I am pregnant?

Human pregnancy data are limited. The US FDA classifies nitazoxanide as Pregnancy Category B (no animal evidence of harm, no controlled human studies). For confirmed giardiasis or cryptosporidiosis in pregnancy, paromomycin (non-absorbed aminoglycoside) is often preferred in the first trimester. Nitazoxanide may be used in second/third trimester after risk-benefit discussion with an obstetrician.

Does Nizonide cure cryptosporidiosis in HIV/AIDS?

Partial response only. In immunocompetent adults nitazoxanide reliably shortens cryptosporidial diarrhoea. In severe immunocompromise (CD4 < 200), response rates are lower and the central intervention is restoration of CD4 count via effective antiretroviral therapy. Higher doses (1000 mg BID) and longer courses (≥ 14 days) are used in HIV under specialist supervision.

Does Nizonide work against COVID-19?

No. Early small studies suggested in-vitro activity but large randomised controlled trials in symptomatic outpatients (PROMINENT-NZX 2022, Rocco 2023) showed no clinically meaningful benefit on viral load, symptom duration, or hospitalisation. Routine use for COVID-19 is not supported.

How long until symptoms improve?

For giardiasis and cryptosporidiosis in immunocompetent adults, most patients notice symptom improvement within 24–72 hours of starting therapy, with full resolution by the end of the 3-day course or shortly after. Persistent diarrhoea beyond day 5 should prompt re-evaluation — possible alternative diagnosis, treatment failure (consider drug exposure with food), or co-infection.

Can I drink alcohol while taking Nizonide?

Yes. Unlike metronidazole and tinidazole, nitazoxanide does ne cause a disulfiram-like reaction with alcohol. Modest alcohol intake during a 3-day course is not dangerous, though hydration, gut rest, and avoiding alcohol while diarrhoea is active are sensible regardless.

Why must I take it with food?

Nitazoxanide is poorly water-soluble. Taking it on an empty stomach gives roughly half the systemic exposure compared with taking it with food — particularly fatty food. Sub-therapeutic absorption is the most common reason for treatment failure. Always take both daily doses with a meal, ideally one containing some fat.

Can I give Nizonide to my child?

Yes, from age 1. Paediatric dosing is age-banded: 1–3 years 100 mg BID; 4–11 years 200 mg BID; 12+ years adult 500 mg BID. Cipla also makes nitazoxanide as a paediatric oral suspension at 100 mg / 5 ml. Safety in infants < 1 year is not established.

How does Nizonide compare with metronidazole for giardiasis?

Comparable cure rates (around 75–85 %) in head-to-head trials. Nitazoxanide advantages: shorter 3-day course (vs 5–7 days for metronidazole), no disulfiram-like alcohol reaction, no metallic taste, generally better tolerated. Metronidazole advantages: more market familiarity, lower cost, available in most healthcare settings. Either is reasonable first-line.

Can Nizonide treat amoebiasis?

Yes for intestinal/luminal amoebiasis (3-day course), with cure rates comparable to metronidazole. For invasive disease (amoebic dysentery, hepatic abscess), metronidazole or tinidazole — followed by a luminal agent like paromomycin to clear cysts — remain the preferred regimen. Always investigate suspected amoebiasis with stool antigen or PCR plus serology when liver involvement is possible.

Other Traveller’s Diarrhoea & Antibiotic Options

Medical Disclaimer. This information is for educational purposes and does not replace individualised clinical advice. Bloody diarrhoea, fever > 39 °C, persistent vomiting, signs of dehydration, or symptoms continuing > 5–7 days warrant urgent medical assessment — particularly after travel to high-risk regions (consider parasitology and stool culture). Pregnancy, infants, the elderly, and immunocompromised patients should consult a clinician before self-treating.

More options in Diarrhoea Treatment

Řazeno podle nedávného objemu objednávek na MedsBase — co si ostatní zákazníci v této kategorii vybírají.

Síla

200 mg, 500 mg

Množství

60 Tablets, 120 Tablets, 180 Tablets, 360 Tablets, 720 Tablets

Hodnocení

Zatím zde nejsou žádná hodnocení

Přidat hodnocení
Nizonide Nizonide
Hodnocení*
0/5
* Hodnocení je povinné
* Odpověď je povinná
Vaše hodnocení
* Hodnocení je povinné
Jméno
* Jméno je povinné
Přidejte fotografie nebo video k vašemu hodnocení

Otázky a odpovědi

Položit otázku
Nizonide Nizonide
Vaše otázka
* Otázka je povinná
Jméno
* Jméno je povinné
Zatím zde nejsou žádné dotazy